Vimarsana
Biggest News Aggregation in the World

Pascal Behr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pascal Behr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pascal Behr Today - Breaking & Trending Today

Cytosurge AG: Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication - Vimarsana News

Cytosurge AG: Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication

CellEDIT Service represents a novel workflow leveraging FluidFM-mediated intranuclear nanoinjection of CRISPR/Cas9 components into single cells.Control of the amount and stoichiometry of RNP complexes

Cytosurge's CellEDIT Workflow, based on its Proprietary - Vimarsana News

Cytosurge's CellEDIT Workflow, based on its Proprietary

CellEDIT uses FluidFM for precise nuclear CRISPR/Cas9 injection, boosting efficiency by controlling RNP amounts, preserving traits in edited CHO-K1 cells....

Rumsey Dec. 11-14 auction series features specialized collections of machine cancels, post office seals, Pacific Mail Steamship Co., Nepal; gems of philately - Vimarsana News

Rumsey Dec. 11-14 auction series features specialized collections of machine cancels, post office seals, Pacific Mail Steamship Co., Nepal; gems of philately

One of the centerpieces of the Barlow collection of U.S. machine cancels is a postcard bearing a marvelous strike of the Seattle, Wash., Exposition Station cancel featuring a stylized U.S. flag and “Alaska-Yukon-Pacific Exposition” on the flag’s stripes.

Source: linns.com
New CRISPR/Cas9 license agreement for ERS Genomics and Cytosurge - Vimarsana News

New CRISPR/Cas9 license agreement for ERS Genomics and Cytosurge

/PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Cytosurge AG ("Cytosurge"). This is a non-exclusive licensing...